Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006-2008

被引：71
|
作者：
Pettus, Liping H. [1 ]
Wurz, Ryan P. [1 ]
机构：
[1] Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2008年 / 8卷 / 16期
关键词：
D O I：
10.2174/156802608786264245
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation. It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease. This article reviews the patent and journal publication activities during 2006-2008 describing novel small molecule p38 alpha inhibitors.
引用
收藏
页码：1452 / 1467
页数：16
相关论文
共 50 条
  • [31] Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases
    Chopra, Puneet
    Kanoje, Vijay
    Semwal, Arvind
    Ray, Abhijit
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (10) : 1411 - 1425
  • [32] A novel small molecule inhibitor of p38α MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation
    Abouleisa, Riham R. E.
    Miller, Jessica M.
    Gebreil, Ahmad
    Salama, Abou Bakr M.
    Dwenger, Marc
    Abdelhafez, Hania
    Wahid, Reham M.
    Adewumi, Adeniyi T.
    Soliman, Mahmoud E. S.
    Abo-Dya, Nader E.
    Mohamed, Tamer M. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (24) : 3271 - 3289
  • [33] Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitors
    Metzger, A
    Diller, DJ
    Lin, TH
    Henderson, I
    Webb, ML
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2006, 9 (05) : 351 - 358
  • [34] Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors
    Roehm, Sandra
    Berger, Benedict-Tilman
    Schroeder, Martin
    Chaikuad, Apirat
    Winkel, Rob
    Hekking, Koen F. W.
    Benningshof, Jorg J. C.
    Mueller, Gerhard
    Tesch, Roberta
    Kudolo, Mark
    Forster, Michael
    Laufer, Stefan
    Knapp, Stefan
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (23) : 10757 - 10782
  • [35] Identification of novel P38 map kinase inhibitors using new glide docking and scoring algorithms.
    Halgren, TA
    Frye, LL
    Greenwood, JR
    Murphy, RB
    Friesner, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U501 - U501
  • [36] Design, Synthesis, and Biological Characterization of Inhaled p38?/? MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases
    Armani, Elisabetta
    Capaldi, Carmelida
    Bagnacani, Valentina
    Saccani, Francesca
    Aquino, Giancarlo
    Puccini, Paola
    Facchinetti, Fabrizio
    Martucci, Cataldo
    Moretto, Nadia
    Villetti, Gino
    Patacchini, Riccardo
    Civelli, Maurizio
    Hurley, Chris
    Jennings, Andrew
    Alcaraz, Lilian
    Bloomfield, Dawn
    Briggs, Michael
    Daly, Stephen
    Panchal, Terry
    Russell, Vince
    Wicks, Sharon
    Finch, Harry
    Fitzgerald, Mary
    Fox, Craig
    Delcanale, Maurizio
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (10) : 7170 - 7192
  • [37] Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2
    Alimbetov, Dauren
    Davis, Terence
    Brook, Amy J. C.
    Cox, Lynne S.
    Faragher, Richard G. A.
    Nurgozhin, Talgat
    Zhumadilov, Zhaxybay
    Kipling, David
    BIOGERONTOLOGY, 2016, 17 (02) : 305 - 315
  • [38] Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2
    Dauren Alimbetov
    Terence Davis
    Amy J. C. Brook
    Lynne S. Cox
    Richard G. A. Faragher
    Talgat Nurgozhin
    Zhaxybay Zhumadilov
    David Kipling
    Biogerontology, 2016, 17 : 305 - 315
  • [39] Dihydro[2,3-C]pyrazole-derivatives: Novel types of p38 MAP kinase inhibitors
    Lehmann, Frank
    Laufer, S.
    INFLAMMATION RESEARCH, 2007, 56 : S445 - S445
  • [40] 5-cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38α MAP kinase
    Liu, CJ
    Wrobleski, ST
    Lin, J
    Ahmed, G
    Metzger, A
    Wityak, J
    Gillooly, KM
    Shuster, DJ
    McIntyre, KW
    Pitt, S
    Shen, DR
    Zhang, RF
    Zhang, HJ
    Doweyko, AM
    Diller, D
    Henderson, I
    Barrish, JC
    Dodd, JH
    Schieven, GL
    Leftheris, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) : 6261 - 6270
12345